Klodian Dhana, MD, PhD; Puja Agarwal, PhD; Bryan D. James, PhD; et al.
ÁñÁ«ÊÓƵ Neurol. 2024;81(3):233-239. doi:10.1001/jamaneurol.2023.5491
This cohort study examines data from Rush Memory and Aging Project, including autopsy results and up to 24 years of follow-up, to determine the association between lifestyle and cognitive function independently of Alzheimer disease pathology burden.
Prashanth S. Ramachandran, MBBS, PhD; Benjamin W. Okaty, PhD; Molly Riehs, BS; et al.
ÁñÁ«ÊÓƵ Neurol. 2024;81(3):240-247. doi:10.1001/jamaneurol.2023.5387
This case-control study investigates if a subset of sudden infant deaths are associated with undiagnosed neuroinflammation and occult infection.
Christian Lund Petersen, MD; Anders Hougaard, MD, PhD; David Gaist, MD, PhD; et al.
has audio
ÁñÁ«ÊÓƵ Neurol. 2024;81(3):248-254. doi:10.1001/jamaneurol.2023.5549
This case-crossover study investigates the association between the use of triptans and risk of stroke and myocardial infarction in patients with ischemic risk factors.
-
Audio:
Risk of Stroke and Myocardial Infarction Among Initiators of Triptans
Nicholas J. Ashton, PhD; Wagner S. Brum; Guglielmo Di Molfetta, MSc; et al.
open access
ÁñÁ«ÊÓƵ Neurol. 2024;81(3):255-263. doi:10.1001/jamaneurol.2023.5319
This cohort study examines data from 3 single-center observational cohorts to test the capabilities of a commercially available plasma phosphorylated tau 217 immunoassay to identify Alzheimer disease pathophysiology.
Adam de Havenon, MD, MS; Lily W. Zhou, MD, MS; Andrew B. Koo, MD; et al.
ÁñÁ«ÊÓƵ Neurol. 2024;81(3):264-272. doi:10.1001/jamaneurol.2023.5416
This cohort study examines data from the National Inpatient Sample to determine trends in the use of endovascular thrombectomy among ischemic stroke patients with and without cardiac interventions.
Nail Benallegue, MD, PhD; Fabien Rollot, MSc; Sandrine Wiertlewski, MD; et al.
open access
ÁñÁ«ÊÓƵ Neurol. 2024;81(3):273-282. doi:10.1001/jamaneurol.2023.5566
This cohort study investigates the optimal initial treatment strategy in pediatric-onset multiple sclerosis to control disease activity.